Suraksha Diagnostic IPO to close on Tuesday, December 3, 2024
Kolkata based Suraksha Diagnostic Limited has raised Rs. 253 crores from 16 anchor investors ahead of its IPO. Some of the leading names like Carnelian Bharat Amritkaal Fund, Societe Generale, Integrated Core Strategies (Asia), Troo Capital, Tusk Investments and mutual funds like Aditya Birla Sunlife MF, Bandhan MF, JM Financial, Kotak MF, Mirae Asset MF, Nippon MF, Quant MF were allocated shares in the anchor book.
The IPO of Suraksha Diagnostic opens on Friday, November 29, 2024 and closes on Tuesday, December 3, 2024 with a Price Band of ₹420 per equity share to ₹441 per equity share.
Suraksha Diagnostics is an integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and medical consultation services.
Suraksha offers a comprehensive range of 2,300+ tests that cover a range of specialties and disciplines. Its diagnostic test menu includes 788 routine pathology tests, 664 specialized pathology tests and 766 radiology tests ranging from basic x-rays, ultrasonography (USG), and computerized tomography (CT) scans to 119 advanced radiology tests such as magnetic resonance imaging (MRI) scans and specialized CT scans. During the Fiscal 2024, it conducted approximately 5.98 million tests serving approximately 1.14 million patients.
According to the CRISIL Report, the diagnostics services market in India was estimated to be around ₹86,000 crores in Fiscal 2024 and is projected to grow to reach approximately ₹127,500 crores by Fiscal 2028.
Additionally, the eastern and north-eastern India was estimated at around ₹17,000 crores in Fiscal 2024 and is projected to grow at a CAGR of around 10.5% to 12.5% to reach approximately ₹26,000 crores by Fiscal 2028.
